Skip to main content
AmigoFish

Managing Toxicities of Pancreatic Cancer therapies: NALIRIFOX, FOLFIRINOX, Gem/Nab-Pac, Daraxonrasib

From Oncology Brothers: Practice-Changing Cancer Discussions · · 22 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

Welcome to the Oncology Brothers podcast! In this episode, we tackled the management of side effects associated with various treatment options for pancreatic cancer. Joined by Dr. Alok Khorana, from Cleveland Clinic and Dr. Weijing Sun, from the University of Kansas Medical Center, the discussion covered:

- Key side effects of newer agents like daraxonrasib, liposomal irinotecan, gemcitabine, and nab-paclitaxel

- The importance of maintaining quality of life for patients with pancreatic cancer

- Insights on the use of leucovorin in treatment regimens and its impact on toxicity

- Clinical pearls for managing common side effects such as diarrhea, neuropathy, and hand-foot syndrome

- Prophylactic measures for minimizing adverse effects from treatments, particularly with daraxonrasib

Join us as we explore the latest advancements in pancreatic cancer treatment and share valuable strategies for improving patient care.

Listen us on:

Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o

Follow us on social media:

•⁠ ⁠X/Twitter: https://x.com/oncbrothers

•⁠ ⁠Instagram: https://www.instagram.com/oncbrothers

•⁠ Website: https://oncbrothers.com/

Don't forget to like, subscribe, and hit the notification bell for more insightful discussions on oncology!

#PancreaticCancer, #SideEffectManagement, #QualityOfLife, #OncologyBrothers

Back to Oncology Brothers: Practice-Changing Cancer Discussions · Report a problem